2011
DOI: 10.1007/s13311-011-0028-2
|View full text |Cite
|
Sign up to set email alerts
|

Cell Cycle Activation and Spinal Cord Injury

Abstract: Summary Traumatic spinal cord injury (SCI) evokes a complex cascade of events with initial mechanical damage leading to secondary injury processes that contribute to further tissue loss and functional impairment. Growing evidence suggests that the cell cycle is activated following SCI. Up-regulation of cell cycle proteins after injury appears to contribute not only to apoptotic cell death of postmitotic cells, including neurons and oligodendrocytes, but also to post-traumatic gliosis and microglial activation.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

4
47
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 62 publications
(51 citation statements)
references
References 93 publications
4
47
0
Order By: Relevance
“…The increased proliferation of activated microglia/macrophages at the lesion site after SCI in p53 Ϫ/Ϫ mice could lead to an aberrant inflammatory response, exacerbated secondary degeneration, and the formation of a more aggressive inhibitory environment, contributing to a more pronounced motor impairment. The inhibition of glial proliferation by several pharmacological strategies including the use of cell cycle inhibitors (Wu et al, 2011), such as Ara-C and Flavopiridol (Rhodes et al, 2003;Di Giovanni et al, 2005c;Byrnes et al, 2007), or the depletion of hematogenous macrophages by liposomeencapsulated clodronate (Popovich et al, 1999), has been shown to enhance axonal sprouting and functional recovery after both brain and spinal cord injury.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The increased proliferation of activated microglia/macrophages at the lesion site after SCI in p53 Ϫ/Ϫ mice could lead to an aberrant inflammatory response, exacerbated secondary degeneration, and the formation of a more aggressive inhibitory environment, contributing to a more pronounced motor impairment. The inhibition of glial proliferation by several pharmacological strategies including the use of cell cycle inhibitors (Wu et al, 2011), such as Ara-C and Flavopiridol (Rhodes et al, 2003;Di Giovanni et al, 2005c;Byrnes et al, 2007), or the depletion of hematogenous macrophages by liposomeencapsulated clodronate (Popovich et al, 1999), has been shown to enhance axonal sprouting and functional recovery after both brain and spinal cord injury.…”
Section: Discussionmentioning
confidence: 99%
“…The glial scar is in fact highly dependent upon the proliferation of reactive astrocytes and microglia/blood-derived macrophages as well as on the degree of cell death at the lesion site (Tian et al, 2006(Tian et al, , 2007Wu et al, 2011).…”
Section: P53mentioning
confidence: 99%
“…in the damaged cord, glial scar formation is markedly reduced, whereas the number of proliferative astrocytes decreases in an astrocyte culture scratch injury model after ethyl pyruvate administration. Moreover, ethyl pyruvate affects activated microglia and CD11b-positive inflammatory cells in an anti-inflammatory fashion.A recent study showed that the delayed expression of cell-cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusion, suggesting that pharmacological agents against cell-cycle proteins ameliorate the non-permissive microenvironment [127] . Specifically, the use of olomoucine to inhibit cell cycle kinases (CDKs) 2 and 5 results in the persistent down-regulation of astroglia [128] and microglia [129] …”
mentioning
confidence: 99%
“…Importantly, this approach also promotes functional axon collateral and regenerative sprouting, as described in the article by Onifer, Smith, and Fouad [18]. Although there are other impediments to axon regeneration in the injured spinal cord environment and intrinsic to the axons themselves, the glial scar can also be attenuated with cell cycle inhibitors and matrix metalloproteinases inhibitors, which is discussed in the articles by Wu, Stoica, and Faden, as well as by Zhang, Chang, Hansen, Basso, and Noble-Haeusslein [10,11] respectively.…”
mentioning
confidence: 99%
“…This third review also describes the ongoing discovery of novel and selective matrix metalloproteinase inhibiting compounds for acute treatment of SCI. The fourth review, largely an inflammation-directed article, by Wu, Stoica, and Faden [11] presents the role of aberrant cell cycle activation in post-traumatic spinal cellular death mechanisms and microglial and astrocytic activation, and the neuroprotective effects of prototypical pharmacological cell cycle inhibitors.…”
mentioning
confidence: 99%